256 related articles for article (PubMed ID: 30670878)
1. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.
Burrage LC; Thistlethwaite L; Stroup BM; Sun Q; Miller MJ; Nagamani SCS; Craigen W; Scaglia F; Sutton VR; Graham B; Kennedy AD; ; Milosavljevic A; Lee BH; Elsea SH
Genet Med; 2019 Sep; 21(9):1977-1986. PubMed ID: 30670878
[TBL] [Abstract][Full Text] [Related]
2. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for liver disease in urea cycle disorders.
Nagamani SCS; Ali S; Izem R; Schady D; Masand P; Shneider BL; Leung DH; Burrage LC
Mol Genet Metab; 2021 Jun; 133(2):148-156. PubMed ID: 33846069
[TBL] [Abstract][Full Text] [Related]
4. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
5. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
Burrage LC; Jain M; Gandolfo L; Lee BH; ; Nagamani SC
Mol Genet Metab; 2014; 113(1-2):131-5. PubMed ID: 25042691
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.
Liu N; Xiao J; Gijavanekar C; Pappan KL; Glinton KE; Shayota BJ; Kennedy AD; Sun Q; Sutton VR; Elsea SH
JAMA Netw Open; 2021 Jul; 4(7):e2114155. PubMed ID: 34251446
[TBL] [Abstract][Full Text] [Related]
7. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism.
Ford L; Kennedy AD; Goodman KD; Pappan KL; Evans AM; Miller LAD; Wulff JE; Wiggs BR; Lennon JJ; Elsea S; Toal DR
J Appl Lab Med; 2020 Mar; 5(2):342-356. PubMed ID: 32445384
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
[TBL] [Abstract][Full Text] [Related]
9. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
[TBL] [Abstract][Full Text] [Related]
10. Untargeted Metabolomics for Metabolic Diagnostic Screening with Automated Data Interpretation Using a Knowledge-Based Algorithm.
Haijes HA; van der Ham M; Prinsen HCMT; Broeks MH; van Hasselt PM; de Sain-van der Velden MGM; Verhoeven-Duif NM; Jans JJM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024143
[TBL] [Abstract][Full Text] [Related]
11. Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism.
Miller MJ; Kennedy AD; Eckhart AD; Burrage LC; Wulff JE; Miller LA; Milburn MV; Ryals JA; Beaudet AL; Sun Q; Sutton VR; Elsea SH
J Inherit Metab Dis; 2015 Nov; 38(6):1029-39. PubMed ID: 25875217
[TBL] [Abstract][Full Text] [Related]
12. Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.
Huemer M; Carvalho DR; Brum JM; Ünal Ö; Coskun T; Weisfeld-Adams JD; Schrager NL; Scholl-Bürgi S; Schlune A; Donner MG; Hersberger M; Gemperle C; Riesner B; Ulmer H; Häberle J; Karall D
J Inherit Metab Dis; 2016 May; 39(3):331-340. PubMed ID: 27038030
[TBL] [Abstract][Full Text] [Related]
13. Contrasting features of urea cycle disorders in human patients and knockout mouse models.
Deignan JL; Cederbaum SD; Grody WW
Mol Genet Metab; 2008 Jan; 93(1):7-14. PubMed ID: 17933574
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolism.
Wurth R; Turgeon C; Stander Z; Oglesbee D
Mol Genet Metab; 2024 Jan; 141(1):108115. PubMed ID: 38181458
[TBL] [Abstract][Full Text] [Related]
15. Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS Platform.
Bonte R; Bongaerts M; Demirdas S; Langendonk JG; Huidekoper HH; Williams M; Onkenhout W; Jacobs EH; Blom HJ; Ruijter GJG
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31779119
[TBL] [Abstract][Full Text] [Related]
16. Clinical metabolomics for inborn errors of metabolism.
Ford L; Mitchell M; Wulff J; Evans A; Kennedy A; Elsea S; Wittmann B; Toal D
Adv Clin Chem; 2022; 107():79-138. PubMed ID: 35337606
[TBL] [Abstract][Full Text] [Related]
17. Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra.
Václavík J; Coene KLM; Vrobel I; Najdekr L; Friedecký D; Karlíková R; Mádrová L; Petsalo A; Engelke UFH; van Wegberg A; Kluijtmans LAJ; Adam T; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):407-414. PubMed ID: 29139026
[TBL] [Abstract][Full Text] [Related]
18. Chronic liver involvement in urea cycle disorders.
Ranucci G; Rigoldi M; Cotugno G; Bernabei SM; Liguori A; Gasperini S; Goffredo BM; Martinelli D; Monti L; Francalanci P; Candusso M; Parini R; Dionisi-Vici C
J Inherit Metab Dis; 2019 Nov; 42(6):1118-1127. PubMed ID: 31260111
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias.
Lichter-Konecki U; Nadkarni V; Moudgil A; Cook N; Poeschl J; Meyer MT; Dimmock D; Baumgart S
Mol Genet Metab; 2013 Aug; 109(4):354-9. PubMed ID: 23791307
[TBL] [Abstract][Full Text] [Related]
20. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
